The kynurenine pathway and quinolinic acid: Pivotal roles in HIV associated neurocognitive disorders

FEBS Journal

Volumn 279, Issue 8, 2012, Pages 1366-1374

  Kandanearatchi, Apsara ^a   Brew, Bruce J ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

dementia; HIV; kynurenine pathway; neurocognitive disorders; quinolinic acid

Indexed keywords

ANTIRETROVIRUS AGENT; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; QUINOLINIC ACID;

AMINO ACID METABOLISM; CEREBROSPINAL FLUID LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS VIRULENCE;

CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; HIV; HIV INFECTIONS; HUMANS; KYNURENINE; QUINOLINIC ACID;

EID: 84859568305     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08500.x     Document Type: Review

References (70)

1. McArthur JC, Brew BJ, &, Nath A, (2005) Neurological complications of HIV infection. Lancet Neurol 4, 543-555.
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders (HAND). Neurology 69, 1789-1799.
3. Cysique LAJ, Maruff P, &, Brew BJ, (2006) Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66, 1447-1450.
4. Cysique LA, &, Brew BJ, (2011) Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of undetectable plasma viral load. J Neurovirol 17, 176-183.
5. Brew BJ, (2010) Benefit or toxicity from neurologically targeted antiretroviral therapy? Clin Infect Dis 50, 930-932.
6. Brew BJ, (2007) AIDS dementia complex. In AIDS, HIV Dementia. Handbook of Clinical Neurology (, Berger J, &, Portegies P, eds), Vol. 85, pp. 79-92. Elsevier, Amsterdam.
7. Brew BJ, Rosenblum M, Cronin K, &, Price RW, (1991) The AIDS dementia complex and human immunodeficiency virus type 1 brain infection: clinical-virological correlations. Ann Neurol 38, 563-570.
8. Glass JD, Fedor H, Wesselingh SL, &, McArthur JC, (1991) Immunocytochemical quantification of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38, 755-762.
9. Ellis R, Langford D, &, Masliah E, (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8, 33-44.
10. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E, & HNRC Group (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. Brain Pathol 9, 209-217.
11. Everall IP, Luthert PJ, &, Lantos PL, (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337, 1119-1121.
12. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, &, Terry R, (1991) Neocortical damage during HIV infection. Ann Neurol 29, 651-657.
13. Cysique LA, Maruff P, &, Brew BJ, (2004) Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 61, 1699-1704.
14. Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, &, Ellis R, (2011) Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS 25, 357-365.
15. Brew BJ, (2007) Lost in translation-again. Another failed neuroprotection trial. Neurology 69, 1308-1309.
16. Nottet HSLM, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai OH, Sharer LR, McComb RD, Swindells S, Soderland C, et al. (1996) Mechanisms for the transendothelial migration of HIV-1 infected monocytes into the brain. J Immunology 156, 1284-1295.
17. Buckner CM, Calderon TM, Willams DW, Belbin TJ, &, Berman JW, (2011) Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell Immunol 267, 109-123.
18. Burdo TH, Ellis RJ, &, Fox HS, (2008) Osteopontin is increased in HIV-associated dementia. J Infect Dis 198, 715-722.
19. Smit TK, Wang B, Ng T, Osborne R, Brew B, &, Saksena NK, (2001) Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. Virology 279, 509-526.
20. Glass JD, Wesselingh SL, Selnes OA, &, McArthur JC, (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43, 2230-2237.
21. Lipton SA, &, Gendelman HE, (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332, 934-940.
22. Brew BJ, (2001) AIDS dementia complex. In HIV Neurology (, Brew BJ, ed.). Contemporary Neurology Series, pp. 53-90. Oxford University Press, Oxford.
23. Kaul M, (2009) HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 22, 315-320.
24. Li W, Galey D, Mattson MP, &, Nath A, (2005) Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox Res 8, 119-134.
25. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, &, Fox HS, (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3, e2906.
26. Nguyen TP, Soukup VM, &, Gelman BB, (2010) Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol 176, 893-902.
27. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, &, Gorry PR, (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66, 253-258.
28. Kaul M, Garden GA, &, Lipton SA, (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994.
29. Borjabad A, Brooks AI, &, Volsky DJ, (2010) Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 5, 44-62.
30. Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, &, Brack-Werner R, (2007) Long-term HIV-1 infection of neural progenitor populations. AIDS 21, 2271-2281.
31. Okamoto S, Kang YJ, Brechtel CW, Siviglia E, Russo R, Clemente A, Harrop A, McKercher S, Kaul M, &, Lipton SA, (2007) HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest. Cell Stem Cell 1, 230-236.
32. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, et al. (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 5-6, 360-370.
33. Anthony IC, &, Bell JE, (2008) The neuropathology of HIV/AIDS. Int Rev Psychiatry 20, 15-24.
34. Pemberton LA, Stone E, Price P, Bockxmeer FM, &, Brew BJ, (2008) The relationship between Apoe, TNFa, IL1a, IL1b And IL12b genes and HIV-1 associated dementia. HIV Med 9, 677-680.
35. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, et al. (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99, 13795-13800.
36. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, et al. (2001) Macrophage tropism of HIV type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor. J Virol 75, 10073-10089.
37. Cinque P, Bestetti A, Morelli P, &, Presi S, (2000) Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system. J Neurovirol 6 (Suppl 1), S95-S102.
38. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, et al. (2006) Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain, 129, 1872-1883.
39. Ohagen A, Devitt A, Kunstman KJ, Gorry PR, Rose PP, Korber B, Taylor J, Levy R, Murphy RL, Wolinsky SM, et al. (2003) Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 77, 12336-12345.
40. Corboy JR, &, Garl PJ, (1997) HIV-1 LTR DNA sequence variation in brain-derived isolates. J Neurovirol 3, 331-341.
41. Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, &, Wigdahl B, (2001) Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J Virol 75, 1842-1856.
42. Davies NWS, Guillemin G, &, Brew BJ, (2010) Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder. Int J Tryptophan Res 3, 121-140.
43. Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA, &, Brew BJ, (2001) Quinolinic acid is produced by macrophages stimulated by PAF, Nef and Tat. J Neurovirol 7, 56-60.
44. Guillemin GJ, Smith DG, Smythe GA, Armati PJ, &, Brew BJ, (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527, 105-112.
45. Guillemin GJ, Smythe G, Takikawa O, &, Brew BJ, (2005) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49, 15-23.
46. Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, &, Brew BJ, (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78, 842-853.
47. Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D, Armati PJ, Crowe SM, &, Brew BJ, (2008) Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem 105, 1346-1357.
48. Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, et al. (2010) Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 16, 279-285.
49. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, &, Mellor AL, (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193.
50. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, et al. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870.
51. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, &, Ferrara GB, (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196, 459-468.
52. Fallarino F, Gizzi S, Mosci P, Grohmann U, &, Puccetti P, (2007) Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. Curr Drug Metab 8, 209-216.
53. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, &, Keilp J, (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29, 202-209.
54. Valle M, Price RW, Nilsson A, Heyes M, &, Verotta D, (2004) CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain 127, 1047-1060.
55. Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, &, Jernigan TL, & HNRC Group (2004) HIV Neurobehavioral Research Center. Elevated CSF QUIN levels are associated with region-specific cerebral volume loss in HIV infection. Brain 124, 1033-1042.
56. Achim CL, Heyes MP, &, Wiley CA, (1993) Quantitation of human immunodeficiency virus immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 91, 2769-2775.
57. Sardar AM, &, Reynolds GP, (1995) Frontal cortex indoleamine-2,3- dioxygenase activity is increased in HIV-1-associated dementia. Neurosci Lett 187, 9-12.
58. Kerr SJ, Armati PJ, &, Brew BJ, (1998) Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 12, 357-365.
59. Heyes MP, Jordan EK, Lee K, Saito K, Frank JA, Snoy PJ, Markey SP, &, Gravell M, (1992) Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Res 570, 237-250.
60. Whetsell WO Jr, &, Schwarcz R, (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97, 271-275.
61. Kerr SJ, Armati PJ, Pemberton LA, Smythe G, Tattam B, &, Brew BJ, (1997) Kynurenine pathway inhibition reducesneurotoxicity of HIV-1 infected macrophages. Neurology 49, 1671-1681.
62. Boasso A, Vaccari M, Fuchs D, Hardy AW, Tsai WP, Tryniszewska E, Shearer GM, &, Franchini G, (2009) Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. J Immunol 182, 4313-4320.
63. Kandanearatchi A, Guillemin GJ, Wilkinson J, Cunningham A, &, Brew BJ, (2007) The kynurenine pathway metabolite quinolinic acid upregulates CCR5 expression. 8th International Symposium on NeuroVirology, San Diego, J Neurovirol 13 (S1), 91.
64. Lee M-C, Ting KK, Adams S, Brew BJ, Chung R, &, Guillemin GJ, (2009) Characterisation of the expression of NMDA receptors in human astrocytes. PLoS ONE 5, e14123.
65. Braidy N, Grant R, Adams S, Brew BJ, &, Guillemin GJ, (2009) Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 16, 77-86.
66. Ting KK, Brew BJ, &, Guillemin GJ, (2009) Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J Neuroinflammation 6, 36.
67. Croitoru-Lamoury J, Lamoury FMJ, Caristo M, Suzuki K, Walker D, Takikawa O, Taylor R, &, Brew BJ, (2011) Interferon-g regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3-dioxygenase (IDO). PLoS ONE 6, e14698.
68. Grant RS, Naif H, Thuruthyil SJ, Nasr N, Littlejohn T, Takikawa O, &, Kapoor V, (2000) Induction of IDO in primary human macrophages by HIV-1 is strain dependent. J Virol 74, 4110-4115.
69. Kandanearatchi A, Wilkinson J, Seddiki N, Zaunders J, Cunningham A, &, Brew BJ, (2010) Neurotropic HIV-1 isolates differentially induce the kynurenine pathway in monocyte derived dendritic cells. International Society for NeuroVirology Meeting, Milan. J Neurovirol 16, 43.
70. Guillemin G, Croitoru J, Dormont D, Armati P, &, Brew BJ, (2003) Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes: implications for brain inflammation in AIDS. Glia 41, 371-381.